![AbbVie to buy ImmunoGen for $10.1 billion to boost cancer drug portfolio](/i/c/34a1ef7d-8312-80a4-62b1-995c961070a3.webp)
AbbVie to buy ImmunoGen for $10.1 billion to boost cancer drug portfolio
AbbVie said on Thursday it will buy drugmaker ImmunoGen for $10.1 billion, boosting its presence in the market
2023-11-30 20:48
![Merck Discontinues Developing Drug Candidates With Sichuan Kelun After Daiichi Sankyo Deal](/i/c/e4ab9707-13a4-2295-87b8-e21843f13774.webp)
Merck Discontinues Developing Drug Candidates With Sichuan Kelun After Daiichi Sankyo Deal
Merck & Co. won’t continue with two drug candidates it previously agreed to co-develop with a Chinese biotech
2023-10-23 13:50
![Novartis Spinoff Sandoz to Start Trading as Standalone Drugmaker](/i/c/57db7df8-52e3-4727-d95e-be3b0e875787.webp)
Novartis Spinoff Sandoz to Start Trading as Standalone Drugmaker
Sandoz Group AG, the maker of copycat medicines, was spun off from drugmaker Novartis AG to begin life
2023-10-04 16:19
![China Drug-Price Negotiations Offers Glimpse Into Future for Companies in US](/i/c/7dd881b5-6401-77a1-4e38-dee82004c039.webp)
China Drug-Price Negotiations Offers Glimpse Into Future for Companies in US
As drugmakers in the US steel for price negotiations ushered in by President Joe Biden’s Inflation Reduction Act,
2023-08-03 10:19
![AbbVie trims full-year profit forecast on higher R&D expenses](/i/c/d14772f5-f70f-629a-5c79-5cdbe30fe8af.webp)
AbbVie trims full-year profit forecast on higher R&D expenses
(Reuters) -AbbVie Inc cut its full-year profit forecast on Thursday, citing $280 million in milestone and in-process research and development
2023-07-07 05:20
![Roivant Attracts Interest for $7 Billion-Plus Bowel Drug](/i/c/caab4954-04e3-b828-efb5-0d555c43d02e.webp)
Roivant Attracts Interest for $7 Billion-Plus Bowel Drug
Roivant Sciences Ltd. is attracting interest from large pharmaceutical companies for its treatment for inflammatory bowel disease, which
2023-07-07 03:21
![Zuckerberg Is Helping to Propel Chicago’s Biotech Ambitions](/i/c/83cd0f4a-bad8-267d-4db4-07236962571d.webp)
Zuckerberg Is Helping to Propel Chicago’s Biotech Ambitions
For about a year, Northwestern University professor Shana Kelley and a group of more than 20 Chicago scientists
2023-06-07 22:51
![Astra Drops Bowel Disease Drug Program After Delays](/i/c/05f5eb61-bea6-0cf4-3717-b24ba3a2071a.webp)
Astra Drops Bowel Disease Drug Program After Delays
AstraZeneca Plc abandoned the development of a medicine in advanced tests called brazikumab for inflammatory bowel diseases like
2023-06-01 15:00
![Teva Plans to Cut Back Generic Drug Production Even As Shortages Intensify](/i/c/c194b88f-e84b-5a37-f226-ca0e599e9aec.webp)
Teva Plans to Cut Back Generic Drug Production Even As Shortages Intensify
Teva Pharmaceutical Industries Ltd. plans to cut back manufacturing of generic drugs, citing low profitability, at a time
2023-05-19 05:15
![Drugmakers Eye $23 Billion Biotech Argenx Ahead of Key Data](/i/c/93d0bb2d-df0a-2bf6-5f8d-050203e227d2.webp)
Drugmakers Eye $23 Billion Biotech Argenx Ahead of Key Data
European biotech firm Argenx SE is scheduled to release key drug trial data this summer. Deal-hungry Big Pharma
2023-05-17 16:20
![Pfizer Sells $31 Billion of Bonds in Fourth-Largest Deal Ever](/i/c/6b23f8d6-301e-882c-f66b-cba09ea50ea6.webp)
Pfizer Sells $31 Billion of Bonds in Fourth-Largest Deal Ever
Pfizer Inc. sold $31 billion of debt in the fourth-largest US bond sale ever, according to a person
2023-05-17 05:23